Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-1135
Breast Implant Market is poised to value USD 3576.76 million by 2028 end at a CAGR of 7.4% during the forecast period 2022 to 2028. Breast implants are artificial medical prosthetics that are used to enhance the natural size of breasts, either for aesthetic purposes or post-mastectomy reconstructive purposes or to rectify abnormalities. The breast implant and augmentation surgery is a substantial investment and thus the socio-economic status of the patient plays a vital role. With close reference to statistics by the American Society of Plastic Surgeons (ASPS), the average cost of a breast augmentation surgery was estimated to be around US$ 3,708. The primary customer base for the global breast implant market being women, their income, purchasing power and economic status is a prime factor. An estimated increase in their earnings, will further supplement their disposable income and thus propel the market in the forecast period. Growth in reimbursement rates for reconstructive and cosmetic purposes are speculated to aid the market’s growth. Widening the range of products as well as substitutes and options in treatments will also lead to the market’s expansion in the forecast timeframe. The multiplying cases of breast cancer have led to the rise in demand for reconstructive surgeries and are estimated to provide lucrative trade to the market in the near future. World Health Organization (WHO), claimed that about 1.7 million women were diagnosed with breast cancer. Hence, an increase in breast cancer prevalence is a major factor contributing to the revenue growth of the global market. The global breast implant market is segmented on the basis of implant type, shape, end-user, and region. Based on implant type, the market is categorized into saline breast implants and silicone breast implants. The silicone breast implants segment is projected to account for a major share of the market in the projected time frame. The significant share of the segment is attributed to comparatively fewer complications associated with it, availability of extensive product line, and cost-efficiency. On the basis of end-user, the market is segmented into hospital & cosmetology clinics. The hospitals' segment is expected to be the more lucrative end-user segment of the market during the forecast period owing to the rising popularity of surgical procedures that are performed in hospitals compared to their counterparts. According to the International Society of Aesthetic Plastic Surgery, the majority of surgical procedures are performed in hospitals accounting for approximately 66.5% share of the global market. North America is expected to hold significant market share in the global breast implant market during the forecast period owing to the rise in awareness and adoption of various breast implant services. Expansion of healthcare infrastructure in the Asia Pacific has boosted trade in the region and is expected to grow at high CAGR during the forecast period. Major firms operating in the market are Allergan Plc., GC Aesthetics Plc., Groupe Sebbin SAS, Mentor Worldwide LLC, Sientra Inc., Polytech Health & Aesthetics GmbH, Establishment Labs S.A., Shanghai Kangning Medical Supplies Ltd., Guangzhou Wanhe Plastic Materials Co., Ltd., LABORATOIRES ARION, HansBiomed Co. Ltd. Breast Implant Market Segmentation: By Product Type Silicone Breast Implants Saline Breast Implants By Shape Round Breast Implants Anatomical Breast Implants By Application Reconstructive Surgery Cosmetic Surgery By End-User Hospitals Cosmetology Clinics Ambulatory Surgical Centers By Region Europe North America APAC Latin America Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways Growth prospects SWOT analysis Key trends Key data points affecting market growth Objectives of the Study: To provide an exhaustive analysis on the global breast implant market by product type, by shape, by application, by end-user, by region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Breast implants are artificial medical prosthetics that are used to enhance the natural size of breasts, either for aesthetic purposes or post-mastectomy reconstructive purposes or to rectify abnormalities.
The breast implant and augmentation surgery is a substantial investment and thus the socio-economic status of the patient plays a vital role. With close reference to statistics by the American Society of Plastic Surgeons (ASPS), the average cost of a breast augmentation surgery was estimated to be around US$ 3,708. The primary customer base for the global breast implant market being women, their income, purchasing power and economic status is a prime factor. An estimated increase in their earnings, will further supplement their disposable income and thus propel the market in the forecast period.
Growth in reimbursement rates for reconstructive and cosmetic purposes are speculated to aid the market’s growth. Widening the range of products as well as substitutes and options in treatments will also lead to the market’s expansion in the forecast timeframe. The multiplying cases of breast cancer have led to the rise in demand for reconstructive surgeries and are estimated to provide lucrative trade to the market in the near future. World Health Organization (WHO), claimed that about 1.7 million women were diagnosed with breast cancer. Hence, an increase in breast cancer prevalence is a major factor contributing to the revenue growth of the global market.
The global breast implant market is segmented on the basis of implant type, shape, end-user, and region. Based on implant type, the market is categorized into saline breast implants and silicone breast implants. The silicone breast implants segment is projected to account for a major share of the market in the projected time frame. The significant share of the segment is attributed to comparatively fewer complications associated with it, availability of extensive product line, and cost-efficiency. On the basis of end-user, the market is segmented into hospital & cosmetology clinics. The hospitals' segment is expected to be the more lucrative end-user segment of the market during the forecast period owing to the rising popularity of surgical procedures that are performed in hospitals compared to their counterparts. According to the International Society of Aesthetic Plastic Surgery, the majority of surgical procedures are performed in hospitals accounting for approximately 66.5% share of the global market.
North America is expected to hold significant market share in the global breast implant market during the forecast period owing to the rise in awareness and adoption of various breast implant services. Expansion of healthcare infrastructure in the Asia Pacific has boosted trade in the region and is expected to grow at high CAGR during the forecast period.
Major firms operating in the market are Allergan Plc., GC Aesthetics Plc., Groupe Sebbin SAS, Mentor Worldwide LLC, Sientra Inc., Polytech Health & Aesthetics GmbH, Establishment Labs S.A., Shanghai Kangning Medical Supplies Ltd., Guangzhou Wanhe Plastic Materials Co., Ltd., LABORATOIRES ARION, HansBiomed Co. Ltd.
Breast Implant Market Segmentation:
By Product Type
By Shape
By Application
By End-User
By Region
Competitive Landscape:
FutureWise Takeaways
Objectives of the Study:
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Breast Implant Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Breast Implant Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Breast Implant Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Breast Implant Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Breast Implant Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Silicone Breast Implants 7.2. Saline Breast Implants 8. Breast Implant Market, By Shape Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Round Breast Implants 8.2. Anatomical Breast Implants 9. Breast Implant Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Cosmetology Clinics 9.3. Ambulatory Surgical Centers 10. Breast Implant Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Reconstructive Surgery 10.2. Cosmetic Surgery 11. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1.GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 17.1. Allergan Plc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. GC Aesthetics Plc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Groupe Sebbin SAS 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Mentor Worldwide LLC 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 Sientra Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 Polytech Health & Aesthetics GmbH 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Establishment Labs S.A. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Shanghai Kangning Medical Supplies Ltd. 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Guangzhou Wanhe Plastic Materials Co., Ltd. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.LABORATOIRES ARION 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11. HansBiomed Co. Ltd. 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Years Considered for the Study
1.3.2. Market Covered
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data
2.1.2.1. Key Data from Primary Sources
2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation
2.4. Assumptions for the Study
3. Executive Summary
3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Breast Implant Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Breast Implant Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Breast Implant Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Breast Implant Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Breast Implant Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
7.1. Silicone Breast Implants
7.2. Saline Breast Implants
8. Breast Implant Market, By Shape Historical Analysis and Forecast 2022-2028 (USD Million)
8.1. Round Breast Implants
8.2. Anatomical Breast Implants
9. Breast Implant Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million)
9.1. Hospitals
9.2. Cosmetology Clinics
9.3. Ambulatory Surgical Centers
10. Breast Implant Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
10.1. Reconstructive Surgery
10.2. Cosmetic Surgery
11. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
11.2.1. U.S.A
11.2.2. Canada
11.2.3. Mexico
11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
12.2.1. Brazil
12.2.2. Venezuela
12.2.3. Argentina
12.2.4. Rest of Latin America
12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
13.2.1. Germany
13.2.2. U.K
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Russia
13.2.7. Poland
13.2.8. Rest of Europe
13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
14.2.1. Japan
14.2.2. China
14.2.3. India
14.2.4. Australia and New Zealand
14.2.5. ASEAN
14.2.6. Rest of Asia Pacific
14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
15.2.1.GCC
15.2.2. Israel
15.2.3. South Africa
15.2.4. Rest of MEA
15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape
16.1. Global Landscape - Key Players, Revenue and Presence
16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
16.3. Global Emerging Companies
16.4. North America - Market Share Analysis and Key Regional Players
16.5. Europe - Market Share Analysis and Key Regional Players
16.6. Asia Pacific - Market Share Analysis and Key Regional Players
16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
17.1. Allergan Plc.
17.1.1. Company Overview
17.1.2. Product Portfolio
17.1.3. SWOT Analysis
17.1.4. Financial Overview
17.1.5. Strategic Overview
17.2. GC Aesthetics Plc.
17.2.1. Company Overview
17.2.2. Product Portfolio
17.2.3. SWOT Analysis
17.2.4. Financial Overview
17.2.5. Strategic Overview
17.3. Groupe Sebbin SAS
17.3.1. Company Overview
17.3.2. Product Portfolio
17.3.3. SWOT Analysis
17.3.4. Financial Overview
17.3.5. Strategic Overview
17.4. Mentor Worldwide LLC
17.4.1. Company Overview
17.4.2. Product Portfolio
17.4.3. SWOT Analysis
17.4.4. Financial Overview
17.4.5. Strategic Overview
17.5 Sientra Inc.
17.5.1. Company Overview
17.5.2. Product Portfolio
17.5.3. SWOT Analysis
17.5.4. Financial Overview
17.5.5. Strategic Overview
17.6 Polytech Health & Aesthetics GmbH
17.6.1. Company Overview
17.6.2. Product Portfolio
17.6.3. SWOT Analysis
17.6.4. Financial Overview
17.6.5. Strategic Overview
17.7. Establishment Labs S.A.
17.7.1. Company Overview
17.7.2. Product Portfolio
17.7.3. SWOT Analysis
17.7.4. Financial Overview
17.7.5. Strategic Overview
17.8. Shanghai Kangning Medical Supplies Ltd.
17.8.1. Company Overview
17.8.2. Product Portfolio
17.8.3. SWOT Analysis
17.8.4. Financial Overview
17.8.5. Strategic Overview
17.9. Guangzhou Wanhe Plastic Materials Co., Ltd.
17.9.1. Company Overview
17.9.2. Product Portfolio
17.9.3. SWOT Analysis
17.9.4. Financial Overview
17.9.5. Strategic Overview
17.10.LABORATOIRES ARION
17.10.1. Company Overview
17.10.2. Product Portfolio
17.10.3. SWOT Analysis
17.10.4. Financial Overview
17.10.5. Strategic Overview
17.11. HansBiomed Co. Ltd.
17.11.1. Company Overview
17.11.2. Product Portfolio
17.11.3. SWOT Analysis
17.11.4. Financial Overview
17.11.5. Strategic Overview 18. Pre and Post COVID-19 Impact
18.1. Positive influence on the healthcare industry
18.2. The financial disruption of the manufacturing sector
18.3. Impact of COVID-19 on emerging companies
18.4. Significant mandates in the healthcare regulations initiated by administrations
18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics